Primary care for you and your family, close to home.
Medical oncologists at Wellstar serve as part of a multidisciplinary care team to help people face cancer with confidence and offer treatments including chemotherapy, targeted therapies, immunotherapy and clinical trials.
At Wellstar, a medical oncologist serves as a person’s primary cancer physician, who is part of each patient’s multidisciplinary team of cancer specialists. We collaborate to build the right care plan for you, which may include cancer drugs, surgery, radiation or a combination of treatments for the most effective outcomes.
We have the latest in genetically based targeted therapies, immunotherapy and chemotherapy to fight various types of cancer. Patients who qualify have access to new or experimental treatments before they are commercially available through clinical trials at select locations. Our patients participate in some of the best clinical trials in Atlanta because of our researchers' reputations and the caliber of our program.
As part of the Mayo Clinic Care Network, oncologists at Wellstar have a direct connection to Mayo Clinic and can request detailed consultations and second opinions, at no additional cost to the patient.
Oncologists at Wellstar are proficient in biomarker testing, which is the hallmark of personalized medicine. Several drugs have been developed which target specific genetic abnormalities in the cancer's DNA. Biomarker tests may determine whether one of these targeted therapies might be effective. These tests can be run with samples obtained from blood, body fluid or tissue.
Immunotherapy is based on the concept that a patient’s own immune system can fight their cancer. When given, immunotherapy drugs wake up the patient’s own immune system to see and fight the cancer. Most recently, the Wellstar Research Institute and Northwest Georgia Oncology Centers have participated in clinical trials that have led to the approval of immunotherapy for breast cancer, gynecologic cancers, lung cancer and kidney cancer.
Chemotherapy is the cancer treatment that has been around the longest. It includes a number of medications—both oral and intravenous—that affect the cancer cell DNA and its ability to divide and grow. Newer chemotherapies have been developed with fewer side effects and newer cancer support drugs—such as anti-nausea medicines—that have improved the chemotherapy experience for patients.
Our patients undergoing chemotherapy for glioblastoma have access to Optune, a newly approved treatment for patients. It is a wearable, portable device that delivers electromagnetic treatment to break down brain tumor DNA.